Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis

Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis

Background & Aims: Treatment with non-selective beta-blockers (NSBBs) reduces the risk of ascites, which is the most common decompensating event in cirrhosis. This study aimed to assess the ability of a serum microRNA (miRNA) signature to predict ascites formation and the hemodynamic respons...

Full description

Saved in:
Bibliographic Details
Main Authors: Ana Garcia Garcia de Paredes, Càndid Villanueva, Carolina Blanco, Joan Genescà, Nicolo Manicardi, Juan Carlos Garcia-Pagan, Jose Luis Calleja, Carlos Aracil, Rosa M. Morillas, Maria Poca, Beatriz Peñas, Salvador Augustin, Juan G. Abraldes, Eldimar Alvarado, Félix Royo, Maria Laura Garcia-Bermejo, Juan Manuel Falcon-Perez, Rafael Bañares, Jaime Bosch, Jordi Gracia-Sancho, Agustin Albillos
Format: article
Language:EN
Published: Elsevier 2021
Subjects:
Ascites
beta-blockers
cirrhosis
microRNA
portal hypertension
Diseases of the digestive system. Gastroenterology
RC799-869
Online Access:https://doaj.org/article/59ab79c9a0de4e2da9fed5699a961c6b
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/59ab79c9a0de4e2da9fed5699a961c6b

Similar Items